NEETPGAI
FeaturesNEET PGFMGEINI-CETBlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • NEET PG Preparation
  • FMGE Preparation
  • INI-CET Preparation
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pharmacology/Antianginals
    Antianginals
    hard
    pill Pharmacology

    A 62-year-old woman with a history of hypertension and dyslipidemia presents with a 2-month history of exertional chest discomfort. Stress ECG shows ST-segment depression in leads II, III, and aVF, consistent with inferior wall ischemia. Coronary angiography reveals 70% stenosis of the right coronary artery. She is started on dual antiplatelet therapy, a statin, and an ACE inhibitor. For antianginal therapy, she is prescribed diltiazem (a non-dihydropyridine calcium channel blocker) 120 mg twice daily. After 1 week, she reports excellent symptom relief. However, she develops fatigue, dyspnea on mild exertion, and a persistent dry cough. On examination, heart rate is 48/min, blood pressure is 110/68 mmHg, and lung auscultation reveals bibasal crackles. Echocardiography shows an ejection fraction of 35% (previously 50%). What is the most likely explanation for her clinical deterioration?

    See the options, answer & explanation

    Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.

    Sign in to see the answerCreate free account

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pharmacology Questions